Compare Ginkgo Bioworks Holdings Inc (DNA) vs Amplify Cybersecurity ETF (HACK) Price & Performance

DNA trades at $9.05, down 0.44% on the day, reflecting ongoing investor caution. The technical outlook is bearish, while fundamentals show significant losses with a net income margin of -201.05% and negative cash flows. Recent earnings have been mixed, missing estimates in two of the last three quarters. Analyst sentiment is divided, with a slight lean toward buy ratings amid high volatility and operational challenges.

The outlook remains challenging due to persistent losses and cash burn, though analyst coverage suggests potential long-term value. Key risks include execution missteps and intense competition in biotechnology. Investment appeal hinges on future profitability improvements and successful business model execution.

HACK trades at $109.28, up 0.28% with a bullish technical outlook supported by strong moving average signals. The cybersecurity ETF benefits from growing sector spending exceeding $300 billion in 2026 and recent momentum hitting 52-week highs. However, overbought RSI readings suggest potential near-term consolidation. The fund captures the expanding cybersecurity market driven by AI-powered threats and increased enterprise security budgets.

The outlook remains positive as cybersecurity becomes essential infrastructure, though elevated valuations and technical overbought conditions present near-term risks. Long-term growth drivers include AI-driven security demands and regulatory compliance requirements, but sector competition and market volatility could pressure returns.